Literature DB >> 18508443

Mesenchymal stem cells transplantation protects against rat pulmonary emphysema.

Guohua Zhen1, Hongmei Liu, Naibing Gu, Huilan Zhang, Yongjian Xu, Zhenxiang Zhang.   

Abstract

Pulmonary emphysema is characterized by loss of alveolar structure. Bone marrow mesenchymal stem cells (MSCs) have been shown to differentiate into alveolar epithelial cells. However, the effect of MSCs transplantation on pulmonary emphysema is unknown. To address this question, cultured bone marrow MSCs from male donor rats were infused into female recipients treated with irradiation and instillation of papain. We found that the emphysematous changes in rats received MSCs transplantation were ameliorated when compared with the rats without MSCs transplantation. Y chromosome fluorescent in situ hybridization (FISH) and immunohistochemical staining for SP-C, confirmed that MSCs engrafted in recipient lungs and differentiated into type II alveolar epithelial cells. Additionally, MSCs transplantation reduced the extent of irradiation and papain-induced alveolar cell apoptosis, likely due to the up-regulation of the expression of Bcl-2 and Bax gene. We conclude that MSCs transplantation protects against the irradiation and papain-induced pulmonary emphysema. The mechanisms of protection may involve the engraftment of MSCs in the lungs, differentiation of MSCs into type II alveolar epithelial cells and suppression of alveolar cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508443     DOI: 10.2741/2936

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  45 in total

1.  A phase I study for intravenous autologous mesenchymal stromal cell administration to patients with severe emphysema.

Authors:  J Stolk; W Broekman; T Mauad; J J Zwaginga; H Roelofs; W E Fibbe; J Oostendorp; I Bajema; M I M Versteegh; C Taube; P S Hiemstra
Journal:  QJM       Date:  2016-01-27

2.  Stem cells and cell therapies in lung biology and diseases: conference report.

Authors:  Daniel J Weiss; Jason H T Bates; Thomas Gilbert; W Conrad Liles; Carolyn Lutzko; Jay Rajagopal; Darwin Prockop
Journal:  Ann Am Thorac Soc       Date:  2013-10

3.  Therapeutic Treatment with Abdominal Adipose Mesenchymal Cells Does Not Prevent Elastase-Induced Emphysema in Rats.

Authors:  Pınar Yıldız Gülhan; Mehmet Savaş Ekici; Mehmet Niyaz; Muhammet Gülhan; Mustafa Emre Erçin; Aydanur Ekici; Nurkan Aksoy
Journal:  Turk Thorac J       Date:  2020-01-01

4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.

Authors:  Piero Anversa; Mark A Perrella; Stella Kourembanas; Augustine M K Choi; Joseph Loscalzo
Journal:  Eur J Clin Invest       Date:  2012-03-21       Impact factor: 4.686

6.  Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.

Authors:  Hong-Mei Liu; Yi-Tong Liu; Jing Zhang; Li-Jun Ma
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

Review 7.  Stem cells and regenerative medicine in lung biology and diseases.

Authors:  Allison N Lau; Meagan Goodwin; Carla F Kim; Daniel J Weiss
Journal:  Mol Ther       Date:  2012-03-06       Impact factor: 11.454

8.  Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1.

Authors:  Xiaohui Fang; Arne P Neyrinck; Michael A Matthay; Jae W Lee
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

Review 9.  Potential application of mesenchymal stem cells in acute lung injury.

Authors:  Jae Woo Lee; Naveen Gupta; Vladimir Serikov; Michael A Matthay
Journal:  Expert Opin Biol Ther       Date:  2009-10       Impact factor: 4.388

10.  Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model.

Authors:  Yunge Zhao; Jacob R Gillen; David A Harris; Irving L Kron; Michael P Murphy; Christine L Lau
Journal:  J Thorac Cardiovasc Surg       Date:  2013-11-04       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.